Latest News from: Yale Cancer Center

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 222
Newswise: Yale Cancer Center researchers demonstrate novel drug increased survival for patients with bladder cancer.

Article ID: 713795

Yale Cancer Center researchers demonstrate novel drug increased survival for patients with bladder cancer.

Yale Cancer Center

There are no approved treatment options for patients with advanced bladder cancer after standard chemotherapy and immune treatments, but the results of a phase II clinical trial led by Yale Cancer Center and Smilow Cancer Hospital researchers demonstrates an effective treatment for this deadly disease.

Released:
3-Jun-2019 7:30 AM EDT
Newswise: New Technique by Yale Cancer Center Scientists May Improve Detection and Treatment of Advanced Brain Cancer

Article ID: 712009

New Technique by Yale Cancer Center Scientists May Improve Detection and Treatment of Advanced Brain Cancer

Yale Cancer Center

In a new study, Yale Cancer Center scientists have demonstrated a powerful method to analyze how tumor cells are altered as they metastasize to the brain.

Released:
29-Apr-2019 8:00 AM EDT
Newswise: Smilow Cancer Hospital and Yale Cancer Center receive grant from Frederick A. DeLuca Foundation to fund Hematology Research Center

Article ID: 711845

Smilow Cancer Hospital and Yale Cancer Center receive grant from Frederick A. DeLuca Foundation to fund Hematology Research Center

Yale Cancer Center

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) are proud to announce a five-year grant awarded by The Frederick A. DeLuca Foundation to establish The DeLuca Center for Innovation in Hematology Research.

Released:
24-Apr-2019 12:30 PM EDT
Newswise: Smilow Cancer Hospital first in Connecticut to perform CAR T-cell therapy

Article ID: 710389

Smilow Cancer Hospital first in Connecticut to perform CAR T-cell therapy

Yale Cancer Center

One of the most promising new generations of cancer treatment called Chimeric Antigen Receptor (CAR) T-cell therapy is now available for patients at Smilow Cancer Hospital. CAR T-cell therapy is groundbreaking immunotherapy that can cure patients with certain blood cancers who have run out of treatment options.

Released:
28-Mar-2019 1:05 PM EDT
Newswise: Yale Cancer Center researchers combine targeted therapies to fight head and neck cancers

Article ID: 708321

Yale Cancer Center researchers combine targeted therapies to fight head and neck cancers

Yale Cancer Center

Yale Cancer Center researchers have identified a potential therapy that combines two types of molecularly targeted drugs to produce a synergistic effect against head and neck cancer.

Released:
19-Feb-2019 2:20 PM EST
Newswise: Yale Cancer Center scientists advise caution in immunotherapy research
  • Embargo expired:
    20-Dec-2018 11:00 AM EST

Article ID: 705690

Yale Cancer Center scientists advise caution in immunotherapy research

Yale Cancer Center

In a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new therapeutic targets.

Released:
19-Dec-2018 12:05 PM EST
Newswise: Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanoma
  • Embargo expired:
    8-Nov-2018 4:00 PM EST

Article ID: 703627

Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanoma

Yale Cancer Center

When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. Published today in the Journal of Clinical Oncology (JCO), a study by Yale Cancer Center researchers show a checkpoint inhibitor immunotherapy drug has meaningful benefit for these patients.

Released:
8-Nov-2018 11:05 AM EST
Newswise: Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital Affiliations

Article ID: 703518

Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital Affiliations

Yale Cancer Center

Branding matters when it comes to choosing a hospital, according to a new novel study by Yale Cancer Center (YCC) researchers published in the journal Annals of Surgical Oncology.

Released:
7-Nov-2018 9:30 AM EST
Newswise: Yale Cancer Center investigators show recommended, but underused treatment for rare blood cancer saves lives

Article ID: 703425

Yale Cancer Center investigators show recommended, but underused treatment for rare blood cancer saves lives

Yale Cancer Center

U.S. and European guidelines on treating Polycythemia Vera (PV), a potentially deadly blood cancer, call for two treatments for patients with high-risk disease: therapeutic phlebotomy and cytoreductive therapy with a drug called hydroxyurea (HU). HU is the most commonly used option, but evidence for HU treatment is limited and both treatments are underused. Now, researchers at Yale Cancer Center have documented reduced risk of death and incidence of blood clots in patients receiving those therapies.

Released:
5-Nov-2018 5:05 PM EST
Newswise: Antonio Omuro named new Neuro-Oncology Chief at Yale Cancer Center

Article ID: 703369

Antonio Omuro named new Neuro-Oncology Chief at Yale Cancer Center

Yale Cancer Center

Antonio Omuro, M.D., has been appointed the new Chief of Neuro-Oncology and a Leader for the Brain Tumor Program at Yale Cancer Center (YCC) and Smilow Cancer Hospital.

Released:
5-Nov-2018 10:45 AM EST

Showing results

110 of 222

Chat now!